Commonwealth Equity Services LLC Sells 1,000 Shares of Liquidia Co. (NASDAQ:LQDA)

Commonwealth Equity Services LLC lowered its position in Liquidia Co. (NASDAQ:LQDA) by 8.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,342 shares of the company’s stock after selling 1,000 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Liquidia were worth $122,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its stake in Liquidia by 9.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 428,570 shares of the company’s stock worth $5,040,000 after acquiring an additional 38,313 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Liquidia by 855.3% during the third quarter. JPMorgan Chase & Co. now owns 235,393 shares of the company’s stock worth $2,354,000 after purchasing an additional 210,753 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Liquidia by 3.3% during the fourth quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company’s stock worth $2,218,000 after purchasing an additional 6,034 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Liquidia by 12.5% in the third quarter. Wellington Management Group LLP now owns 179,923 shares of the company’s stock worth $1,799,000 after purchasing an additional 19,932 shares during the last quarter. Finally, Swiss National Bank raised its stake in Liquidia by 20.6% in the fourth quarter. Swiss National Bank now owns 107,900 shares of the company’s stock valued at $1,269,000 after purchasing an additional 18,400 shares in the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on LQDA. HC Wainwright reissued a “buy” rating and issued a $29.00 price target on shares of Liquidia in a research note on Thursday, March 20th. Needham & Company LLC reiterated a “buy” rating and issued a $25.00 target price on shares of Liquidia in a research report on Thursday. Scotiabank restated an “outperform” rating on shares of Liquidia in a research report on Thursday, March 20th. Finally, Wells Fargo & Company started coverage on Liquidia in a report on Friday, December 20th. They issued an “overweight” rating and a $20.00 price objective for the company. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $26.63.

Insider Activity

In other Liquidia news, CEO Roger Jeffs sold 22,343 shares of the company’s stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total transaction of $263,200.54. Following the completion of the transaction, the chief executive officer now owns 1,019,177 shares of the company’s stock, valued at $12,005,905.06. This represents a 2.15 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Michael Kaseta sold 23,370 shares of Liquidia stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total value of $275,298.60. Following the completion of the sale, the chief financial officer now owns 401,755 shares in the company, valued at approximately $4,732,673.90. This represents a 5.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 71,245 shares of company stock valued at $843,326. 30.10% of the stock is currently owned by company insiders.

Liquidia Stock Down 3.0 %

NASDAQ LQDA opened at $12.39 on Friday. The company has a 50-day simple moving average of $14.91 and a two-hundred day simple moving average of $12.65. Liquidia Co. has a 12-month low of $8.26 and a 12-month high of $16.81. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of -7.60 and a beta of 0.23.

Liquidia (NASDAQ:LQDA) last issued its earnings results on Wednesday, March 19th. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The company had revenue of $2.92 million for the quarter, compared to analysts’ expectations of $4.60 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. Equities analysts expect that Liquidia Co. will post -1.51 earnings per share for the current fiscal year.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).